org placeholder image

Robin Selsor

Director Strategic Accounts at Aimmune Therapeutics

  • LinkedIn

Email Email: r****@aimmune.com

phone noPhone Number: (***)-***-****

map
AIMMUNE THERAPEUTICS

AIMMUNE THERAPEUTICS

  • description Description
    Aimmune Therapeutics, Inc., a Nestle Health Science Company, is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies. With a m...

    Read More

  • Employees count Employees 501-1000
  • Revenue Revenue 1 Million to 5 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Aimmune Therapeutics Org Chart and Mapping

Employees

Joseph Degaetano

Senior Manager, Quality Control Clinical Programs

Clarissa Mandap

Senior Clinical Research Associate

Benjamin Blodgett

Associate Director, Market Access, Pricing and Contracting

Cindi Hein

Regional Director, Hospital Sales West at Aimmune Therapeutics a Nestle Health Science Company

Frequently Asked Questions Regarding Robin Selsor

Answer: Robin Selsor works for Aimmune Therapeutics as Director Strategic Accounts

Answer: Robin Selsor’s role in Aimmune Therapeutics is Director Strategic Accounts

Answer: Robin Selsor's email address is r***@gmail.com

Answer: Robin Selsor's business email address is r****@aimmune.com

Answer: Robin Selsor’s direct phone number is (***)-***-****

Answer: Robin Selsor works in the industry of: Biotechnology

Answer: Robin Selsor works Aimmune Therapeutics located at 8000 Marina BLVD Ste 300, Brisbane, California, 94005, United States

Answer: Aimmune Therapeutics's Director Strategic Accounts is Robin Selsor

Answer: Robin Selsor contact details:

  • Phone number  :  (***)-***-****
  • Email  :  r****@aimmune.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access